COMMUNIQUÉS West-GlobeNewswire

Idorsia announces financial results for the first half of 2019
23/07/2019
Allschwil, Switzerland – July 23, 2019 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first half of 2019. Key figures US GAAP operating expenses HY 2019 at CHF 252 million Non-GAAP operating [...]
WW Schedules Second Quarter 2019 Earnings Conference Call
22/07/2019
NEW YORK, July 22, 2019 (GLOBE NEWSWIRE) -- Weight Watchers International, Inc. (NASDAQ: WW) will release its results for the second quarter 2019 after market close on Tuesday, August 6, 2019. WW will host a conference [...]
Organogenesis Holdings Commences Offer to Exchange Class A Common Stock for any and all Outstanding Public Warrants and Consent Solicitation
22/07/2019
CANTON, Mass., July 22, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO) (the “Company,” “we” or “our”) today announced that it has commenced an offer to exchange (“Offer to Exchange”) 0.095 shares of [...]
GenMark Diagnostics Schedules Second Quarter 2019 Financial Results Conference Call for August 5, 2019
22/07/2019
CARLSBAD, Calif., July 22, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its second quarter earnings results after market close on Monday, August 5, 2019. [...]
Silk Road Medical to Report Second Quarter 2019 Financial Results on July 29, 2019
22/07/2019
SUNNYVALE, Calif., July 22, 2019 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results [...]
Genesis HealthCare to Release Second Quarter 2019 Results on August 8, 2019
22/07/2019
KENNETT SQUARE, Pa., July 22, 2019 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE:GEN) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today announced that it expects to release its [...]
Myovant Sciences to Host Webcast and Conference Call at 8:30 a.m. Eastern Time Tuesday, July 23rd to Discuss Results from Second Phase 3 Study Evaluating Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids and from Bioequivalence Study
22/07/2019
BRISBANE, Calif. and BASEL, Switzerland, July 22, 2019 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE:MYOV), a clinical-stage healthcare company focused on developing and commercializing innovative therapies for women’s [...]
Forty Seven, Inc. Announces Closing of Underwritten Public Offering and Exercise in Full of Option to Purchase Additional Shares
22/07/2019
MENLO PARK, Calif., July 22, 2019 (GLOBE NEWSWIRE) -- Forty Seven, Inc. (Nasdaq: FTSV), a clinical stage immuno-oncology company, today announced the closing of its previously announced public offering of 10,781,250 [...]
Cytokinetics Announces Preclinical Data Relating to CK-3773274 to be Presented at the American Heart Association’s Basic Cardiovascular Sciences Scientific Sessions
22/07/2019
SOUTH SAN FRANCISCO, Calif., July 22, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that two preclinical poster presentations relating to CK-3773274 (CK-274) will be presented at the [...]
BioCorRx’s Director Louis Lucido Appeared Today on Yahoo Finance LIVE “On the Move”
22/07/2019
ANAHEIM, CA, July 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a leader, developer and provider of advanced solutions in the treatment of addiction and related disorders [...]
ContraVir Pharmaceuticals Announces Name Change to Hepion Pharmaceuticals, Inc.; Trading Symbol Change to “HEPA”
22/07/2019
EDISON, N.J., July 22, 2019 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from [...]
Endonovo Therapeutics Inc. Featured in Exclusive NetworkNewsWire Broadcast
22/07/2019
NEW YORK, July 22, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Endonovo Therapeutics Inc. (OTCQB: ENDV), an innovative biotechnology company and commercial-stage developer of noninvasive Electroceutical™ therapeutic [...]
Transactions in relation to share buyback program
22/07/2019
Announcement no. 43/2019 22 July 2019 Transactions in relation to share buyback program On 14 May 2019, Össur hf. initiated a share buy-back program, see Company announcement no. 31/2019. The purpose of the share [...]
Veloxis Revises Outlook for 2019 Based on Strong Performance
22/07/2019
Company Release no. 11/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 22 July 2019 Veloxis Revises Outlook for 2019 Based on Strong Performance Veloxis Pharmaceuticals A/S (OMX: VELO) announced today that it is [...]
ASIT biotech Raises EUR 9.225 Million in a Private Placement of Convertible Notes
22/07/2019
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO [...]
Genmab Announces the Completion of its Initial Public Offering of American Depositary Shares (ADSs) in the United States and Registration of Capital Increase
22/07/2019
Company Announcement Genmab A/S has today completed its initial public offering of American Depositary Shares in the United States and registered a capital increase of 2,850,000 ordinary shares in connection with the [...]
Global Expansion Efforts Begin Yielding Results
22/07/2019
Asia is the first Key Geographic Focal Point NEW HAVEN, Conn., July 22, 2019 (GLOBE NEWSWIRE) -- Specialty Diagnostics company Precipio, Inc . ( NASDAQ: PRPO ), announced today that in conjunction with its global [...]
Bhang CBD Products Now Available in Cannabis Now’s Flagship Beverly Hills Location
22/07/2019
MIAMI, July 22, 2019 (GLOBE NEWSWIRE) -- Bhang Inc. (“Bhang” or the “Company”) (CSE: BHNG) , a trusted cannabis house of brands with an extensive, award-winning portfolio of over 100 cannabis, hemp-derived cannabidiol ( [...]
Innovation Pharmaceuticals Announces License Agreement with Alfasigma S.p.A. for the Development and Commercialization of Brilacidin in Ulcerative Proctitis/Ulcerative Proctosigmoiditis
22/07/2019
Over $24M in initial and milestone-based payments BEVERLY, Mass., July 22, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to [...]

Pages